Hepatitis B

Recipients of Popular Facial May Have Been Exposed to HIV, Hepatitis

Recipients of Popular Facial May Have Been Exposed to HIV, Hepatitis

Inspection at the VIP Spa in Albuquerque detected practices that might spread HIV or hepatitis B and C.

NFID Initiative Working to Up Hepatitis B Vaccination Rates

NFID Initiative Working to Up Hepatitis B Vaccination Rates

A new initiative to increase hepatitis B virus vaccination rates among at-risk adults has been developed.

Novel Hepatitis B Virus Treatment Gets FDA's Fast Track Designation

Novel Hepatitis B Virus Treatment Gets FDA's Fast Track Designation

By

The FDA has granted Fast Track designation to a novel antiviral in development for the treatment of HBV infection.

Long-Term Safety Data for Tenofovir Alafenamide in Chronic Hepatitis B Added to Labeling

Long-Term Safety Data for Tenofovir Alafenamide in Chronic Hepatitis B Added to Labeling

By

Vemlidy, a nucleoside analogue (reverse transcriptase inhibitor), is currently approved to treat chronic hepatitis B virus (HBV) infection in adults with compensated liver disease.

Hepatitis B Vaccines Compared in Older Adults With Type 2 Diabetes

Hepatitis B Vaccines Compared in Older Adults With Type 2 Diabetes

By

For the analysis, study authors looked at data specifically for patients with type 2 diabetes aged 60 to 70 years.

HBV Status Linked to Disease Activity and Progression in Rheumatoid Arthritis

HBV Status Linked to Disease Activity and Progression in Rheumatoid Arthritis

Patients with rheumatoid arthritis with chronic hepatitis B virus infection demonstrated greater radiographic progression and poorer clinical response at 1 year.

MenACWY-TT Vaccine Can Be Effectively Coadministered With Routine Pediatric Immunizations

MenACWY-TT Vaccine Can Be Effectively Coadministered With Routine Pediatric Immunizations

By

Study showed that DTPa-HBV-IPV/Hib and PHiD-CV coadministered with MenACWY-TT in infants and toddlers were immunogenic with an acceptable reactogenicity profile.

HBV Reactivation Examined in Patients Treated With TNF Antagonists

HBV Reactivation Examined in Patients Treated With TNF Antagonists

By

The authors examined data from 8887 individuals who began TNF antagonist treatment for an autoimmune disease from 2001 through 2010 and were followed through 2012; 52% of these patients were screened for HBV before treatment.

Infections Complicating the Use of Monoclonal Antibodies for Malignancy

Infections Complicating the Use of Monoclonal Antibodies for Malignancy

By

In this review, David C. Helfgott, MD, editorial advisory board member for Infectious Disease Advisor, focuses on infectious complications from the use of monoclonal antibodies for malignancy.

Metabolic Syndrome Associated With Higher ALT Levels in Chronic Hepatitis B

Metabolic Syndrome Associated With Higher ALT Levels in Chronic Hepatitis B

By

Findings highlight the importance of screening for metabolic syndrome (MS) and the potential for MS to influence alanine aminotransferase and its interpretation in the context of HBV treatment decisions.

Maternal Use of TDF Does Not Further Reduce HBV Transmission

Maternal Use of TDF Does Not Further Reduce HBV Transmission

Maternal use of tenofovir disoproxil fumarate does not lower hepatitis B virus transmission rates.

BMI Linked to Hepatocellular Carcinoma Risk in Chronic Hepatitis B Virus

BMI Linked to Hepatocellular Carcinoma Risk in Chronic Hepatitis B Virus

For patients with chronic HBV, BMI is significantly associated with increased risk of hepatocellular carcinoma.

No difference between tenofovir and placebo in reducing perinatal transmission of hepatitis B

Hepatitis B e-antigen positive mothers receiving tenofovir daily from 28-weeks gestation to 2 months postpartum did not show significant reductions in HBV transmission rates compared to placebo treated participants.

ACIP Votes in Favor of Heplisav-B for Hepatitis B Prevention in Adults

ACIP Votes in Favor of Heplisav-B for Hepatitis B Prevention in Adults

By

The FDA approval of Heplisav-B was based on data from 3 phase 3 noninferiority trials involving close to 10,000 adults who received the vaccine.

ACIP Issues Updated Recommendations for Preventing HBV Infection

ACIP Issues Updated Recommendations for Preventing HBV Infection

By

The Advisory Committee on Immunization Practices has issued updated recommendations for HBV prevention.

New Two-Dose Hepatitis B Vaccine for Adults Now Available

New Two-Dose Hepatitis B Vaccine for Adults Now Available

By

Dynavax Technologies announced the availability of a two-dose hepatitis B vaccine for adults.

Over one-third of U.S. HIV patients are not vaccinated against hepatitis B

One third of HIV patients in the United States (U.S.) remain unvaccinated against hepatitis B. Of HIV patients who were candidates for hepatitis B vaccination, only 1 in 10 were vaccinated within 1 year of continuing care for HIV.

Hepatitis B Vaccination Prevalence Low in Patients With HIV

Hepatitis B Vaccination Prevalence Low in Patients With HIV

More than one-third of adult US HIV patients miss opportunities to initiate hepatitis B vaccination.

HBV, HCV Increases All-Cause, Liver-Related Mortality in HIV

HBV, HCV Increases All-Cause, Liver-Related Mortality in HIV

By

Hepatitis B and hepatitis C may increase mortality risks in patients with HIV.

Liver Damage Worse in Women With HBV/HCV Coinfection, Risky Drinking

Liver Damage Worse in Women With HBV/HCV Coinfection, Risky Drinking

By

The combined presence of alcohol abuse, HBV, and HCV generates an additive effect on the risk of cirrhosis in women than in men.

Association Between HBV, HCV and Age-Related Cataracts

Association Between HBV, HCV and Age-Related Cataracts

By

High aspartate aminotransferase levels completely mediated the effects of HBV infection on any cataract.

Elevated Levels of HBV DNA and HBsAg May Increase Liver Cancer Risk

Elevated Levels of HBV DNA and HBsAg May Increase Liver Cancer Risk

Elevated levels of hepatitis B virus DNA and hepatitis B surface antigen are associated with increased risks of liver cancer.

ACP, CDC Provides Best Practice Advice on Hepatitis B Management

ACP, CDC Provides Best Practice Advice on Hepatitis B Management

By

Screening, vaccination, and linkage to care will reduce the high costs associated with hepatitis B infection.

Preventing HBV Reactivation During Immunosuppressive Treatment

Preventing HBV Reactivation During Immunosuppressive Treatment

By

Although it is commonly accepted that lamivudine prophylaxis should be started a few weeks before chemotherapy is administered, the best time for lamivudine discontinuation is still controversial.

FDA Approves New Hepatitis B Vaccine for Adults

FDA Approves New Hepatitis B Vaccine for Adults

By

The FDA approves new hepatitis B virus vaccine for adults.

Aspirin May Lower Risk of HBV-Related Hepatocellular Carcinoma

Aspirin May Lower Risk of HBV-Related Hepatocellular Carcinoma

By

Patients who take aspirin may significantly reduce their risk of hepatitis B-related hepatocellular carcinoma.

Treating Hepatocellular Carcinoma: A Fight Against the Odds

Treating Hepatocellular Carcinoma: A Fight Against the Odds

By

Despite continual efforts aimed at finding new treatment options, HCC still has a very low 5-year survival rate, less than 20%, as many patients are diagnosed at an advanced stage of the disease.

Hepatitis B Reactivation Rate Linked to Inflammatory Arthritis Treatment

Hepatitis B Reactivation Rate Linked to Inflammatory Arthritis Treatment

By

Hepatitis B virus reactivation rates differ in patients with inflammatory arthritis.

Hepatitis B, Hepatitis C, HIV More Common in Severe Mental Illness

Hepatitis B, Hepatitis C, HIV More Common in Severe Mental Illness

By

HIV, hepatitis B, and hepatitis C infections are more prevalent among patients with severe mental illness than in the general population.

AAP: Hepatitis B Vaccine Should Be Given Within 24 Hours of Birth

AAP: Hepatitis B Vaccine Should Be Given Within 24 Hours of Birth

The first dose of the hepatitis B vaccine should be given within the first 24 hours of life.

Sign Up for Free e-newsletters